Report
Valens Research

PAH - Embedded Expectations Analysis - 2018 07 25

Platform Specialty Products Corporation (PAH:USA) currently trades near historical averages relative to UAFRS-based (Uniform) Earnings, with an 11.5x Uniform P/E. At these levels, the market has bearish expectations for the firm, and management has concerns about margins and their product mix

Specifically, management appears to lack confidence in their ability to sustain recent performance, and may be concerned in particular about their performance in core electronics and in herbicides in Brazil. Management may also lack confidence in their 2014 acquisition of AG Solutions. Furthermore, the team may be concerned about cost pressure the business faces from Chinese suppliers, and temporary inefficiencies from plant rationalization costs
Underlying
PLATFORM SPECIALTY PRODUCTS

Platform Specialty Products is a producer of chemical products. The company's business involves the formulation of a range of chemicals, which are sold into various industries, including agricultural, animal health, electronics, and graphic arts. The company manages its business in two reportable segments: Performance Solutions, which formulates and markets chemistry solutions that are used in electronics, automotive production, oil and gas production, drilling, commercial packaging and printing; and Agricultural Solutions, which provides to growers a range crop protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch